Arriving in the arena of weight management treatment, retatrutide represents a different strategy. Different from many available medications, retatrutide works as a dual agonist, at once affecting both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) binding sites. The concurrent activation encourages various helpful effe